Safety, Tolerability and Activity Study of Multiple Doses of ISIS-SGLT2Rx in Healthy Volunteers
Status:
Completed
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this trial is to assess the safety and tolerability of ISIS-SGLT2Rx
when given at increasing single doses and to assess the safety and tolerability of the same
doses when given multiple times.